Introductory Chapter: Protein Kinases as Promising Targets for Drug Design against Cancer
Author:
Abstract
Publisher
IntechOpen
Link
http://www.intechopen.com/download/pdf/78859
Reference85 articles.
1. Bhatia R, Rawal RK. Coumarin hybrids: Promising scaffolds in the treatment of breast cancer. Mini Reviews in Medicinal Chemistry. 2019;19(17):1443-1458
2. Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. Journal of Thoracic Disease. 2017;9(3):448-451
3. Bhullar KS, Lagarón NO, McGowan EM, et al. Kinase-targeted cancer therapies: Progress, challenges and future directions. Molecular Cancer. 2018;17:48
4. Berndt N, Karim RM, Schönbrunn E. Advances of small molecule targeting of kinases. Current Opinion in Chemical Biology. 2017;39:126-132
5. Cohen P, Cross D, Jänne PA. Kinase drug discovery 20 years after imatinib: Progress and future directions. Nature Reviews. Drug Discovery. 2021;20:551-569
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A multifaceted approach for the development of novel Hantzsch 1,4-dihydropyridines as anticancer agents: Rational design, parallel synthesis, analysis, cytotoxicity and EGFR/HER2 inhibition studies;Results in Chemistry;2024-01
2. Clinical Application of Individualized 3D-Printed Chest Wall Conformal Device in IMRT for Post-mastectomy Breast Cancer;Current Medical Imaging Formerly Current Medical Imaging Reviews;2023-08-16
3. Novel Phthalic-Based Anticancer Tyrosine Kinase Inhibitors: Design, Synthesis and Biological Activity;Current Issues in Molecular Biology;2023-02-22
4. Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy;Pharmaceutics;2022-12-03
5. Progress in Nitrogen and Oxygen-based Heterocyclic Compounds for their Anticancer Activity: An Updates (2017-2020);Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I;2022-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3